I. Turchin

发表

International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis.

Vinod K. Sharma, M. Lebwohl, A. Oakley, 2022, JAMA dermatology.

B. Barankin, I. Turchin, 2007 .

Cigarette Smoking and Cutaneous Damage in Systemic Lupus Erythematosus

C. Pineau, S. Bernatsky, A. Clarke, 2009, The Journal of Rheumatology.

Real‐world, long‐term treatment patterns of commonly used biologics in Canadian patients with moderate‐to‐severe chronic plaque psoriasis

M. Gooderham, K. Papp, C. Lynde, 2021, The Journal of dermatology.

Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper

M. Gooderham, K. Papp, Y. Poulin, 2020, Journal of cutaneous medicine and surgery.

The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases

M. Bourcier, I. Turchin, 2022, Advances in Therapy.

Tazarotene 0.1% Cream as Monotherapy for Early-Stage Cutaneous T-Cell Lymphoma

D. Roberge, I. Turchin, K. Pehr, 2016, Journal of cutaneous medicine and surgery.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section III: Evaluation of Atopic Dermatitis Patients for Comorbidities

M. Wiseman, M. Gooderham, C. Hong, 2018, Journal of cutaneous medicine and surgery.

Review and Practical Guidance on Managing Fungal Infections in Patients With Psoriasis Receiving Anti-IL-17 Therapies

C. Lynde, R. Vender, J. Yeung, 2022, Journal of cutaneous medicine and surgery.

Follow-up of Patients With Keratinocyte Carcinoma: A Systematic Review of Clinical Practice Guidelines.

A. Drucker, M. Gooderham, K. Papp, 2022, JAMA dermatology.

Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway

M. Gooderham, K. Papp, R. Vender, 2022, Journal of cutaneous medicine and surgery.

Skimming the surface: a brief history of skin conditions.

I. Turchin, S. Adams, 2005, Canadian family physician Medecin de famille canadien.

Emerging paradigm shift toward proactive topical treatment of psoriasis: A narrative review

M. Wiseman, M. Gooderham, K. Papp, 2021, Dermatologic therapy.

Dermacase. Dermatophyte infection (tinea).

L. Saxinger, B. Barankin, I. Turchin, 2005, Canadian family physician Medecin de famille canadien.

Clinical Insights About Onychomycosis and Its Treatment: A Consensus.

Aaron M. King, Davindra Singh, S. Kalia, 2018, Journal of drugs in dermatology : JDD.

Practical Management of Patients with Atopic Dermatitis on Dupilumab

M. Gooderham, K. Papp, R. Bissonnette, 2021, Dermatology and Therapy.

Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis

N. Sadick, K. Papp, S. Tyring, 2021, Journal of dermatological treatment (Print).

Nonstationary Axisymmetric Temperature Field in a Two-Layer Slab Under Mixed Heating Conditions

I. Turchin, I. Timár, Yu. A. Kolodii, 2015 .

Management of moderate‐to‐severe plaque psoriasis with biologics: A treat‐to‐target position paper

M. Gooderham, C. Lynde, R. Vender, 2022, Dermatologic therapy.

Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel

J. Lambert, S. Hotte, M. Gooderham, 2023, Dermatology and Therapy.

Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial

A. Kimball, E. Prens, E. Maverakis, 2023, Dermatology and Therapy.

Expert consensus on the systemic treatment of atopic dermatitis in special populations

M. Gooderham, K. Papp, C. Lynde, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review

M. Barakat, R. Vender, J. Yeung, 2022, JAAD international.

Brodalumab success in patients with moderate-to-severe psoriasis who failed previous IL17A inhibitors.

R. Shukla, M. Barakat, R. Vender, 2020, Journal of the American Academy of Dermatology.

Roflumilast Cream 0.3% Improved the Severity and Impact of Itch in Patients With Chronic Plaque Psoriasis in the Phase 3 DERMIS-1 and DERMIS-2 Studies

M. Lebwohl, M. Gooderham, K. Papp, 2021, SKIN The Journal of Cutaneous Medicine.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document

M. Wiseman, M. Gooderham, K. Papp, 2018, Journal of Cutaneous Medicine and Surgery.

Cross‐reactions among Parabens, para‐Phenylenediamine, and Benzocaine: A Retrospective Analysis of Patch Testing

E. Warshaw, D. Sasseville, I. Turchin, 2006, Dermatitis : contact, atopic, occupational, drug.

Assessing Skin Cancer Risk Factors, Sun Safety Behaviors and Melanoma Concern in Atlantic Canada: A Comprehensive Survey Study

E. Rahme, W. Gulliver, S. Peláez, 2023, Cancers.

Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective.

M. Wiseman, M. Gooderham, C. Lynde, 2023, Journal of the American Academy of Dermatology.

Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

W. Gulliver, M. Gooderham, K. Papp, 2023, Journal of cutaneous medicine and surgery.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis

M. Wiseman, M. Gooderham, K. Papp, 2018, Journal of cutaneous medicine and surgery.

Dermacase. Chronic venous insufficiency.

B. Barankin, I. Turchin, 2006, Canadian family physician Medecin de famille canadien.

Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis

C. Maari, I. Turchin, R. Vender, 2024, Dermatology and therapy.